Skip to product information
1 of 1

GeneBio Systems

Purified Anti-Human CD134 Antibody[Ber-ACT35]

Purified Anti-Human CD134 Antibody[Ber-ACT35]

SKU:GBS-F1153A

Regular price $796.00 USD
Regular price Sale price $796.00 USD
Sale Sold out
Shipping calculated at checkout.

Size:1mg

Storage:Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

Shipping:Ice bag

Exp date:12 months

Category ID_II:Primary Antibodies

Category ID_III:Flow Cytometry Antibodies

Abbreviation:CD134

Target Synonym:IMD;ACT;Tumor necrosis factor receptor superfamily member;Txgp;TNFRSF;TNFRSF4;ACT35;CD134;IMD16;OX40;TXGP1L;ACT35 antigen;OX40L receptor;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (C-Fc-Avi);Recombinant Human OX40/TNFRSF4 Protein (C-mFc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc);Tumor necrosis factor receptor superfamily member 4;Txgp1;OX-40; TNFRSF4;Recombinant Human OX40/TNFRSF4 Protein (C-Fc);Recombinant Human OX40/TNFRSF4 Protein (N-Fc)

Research Areas:Immunology;Stem Cells

Conjugation:Unconjugated

Host:Mouse

Species reactivity:Human

Application:FCM

Usage:

Isotype:Mouse IgG1,κ

Clonality:Monoclonal

Clone NO.:Ber-ACT35

UNIProt ID:P43489

Background:The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell prolifeRation and differentiation.

Concentration:≥ 1 mg/mL

Control catalog number:

Immunogen:Recombinant Human CD134 protein

Buffer:PBS, pH 7.2. Contains 0.05% proclin 300.

Purification method:>98%, Protein A/G purified

Dilution:FCM 2 μg/mL(0.5×106-1×106 cells)

GeneID:7293

View full details